KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Vir Biotechnology (VIR) over the last 7 years, with Q3 2025 value amounting to 0.63%.

  • Vir Biotechnology's Return on Invested Capital fell 1800.0% to 0.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 0.43% for FY2024, which is 600.0% down from last year.
  • Vir Biotechnology's Return on Invested Capital amounted to 0.63% in Q3 2025, which was down 1800.0% from 0.6% recorded in Q2 2025.
  • Over the past 5 years, Vir Biotechnology's Return on Invested Capital peaked at 0.69% during Q1 2022, and registered a low of 0.63% during Q3 2025.
  • For the 5-year period, Vir Biotechnology's Return on Invested Capital averaged around 0.18%, with its median value being 0.37% (2024).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first soared by 12400bps in 2022, then crashed by -9600bps in 2023.
  • Vir Biotechnology's Return on Invested Capital (Quarter) stood at 0.34% in 2021, then decreased by -21bps to 0.27% in 2022, then crashed by -252bps to 0.41% in 2023, then decreased by -19bps to 0.49% in 2024, then dropped by -29bps to 0.63% in 2025.
  • Its last three reported values are 0.63% in Q3 2025, 0.6% for Q2 2025, and 0.58% during Q1 2025.